+1-888-308-5802      . .

Amylyx Pharmaceuticals bags first approval for ALS drug from Canada

Author : Pankaj Singh | Published Date : 2022-06-14 

Amylyx Pharmaceuticals bags first approval for ALS drug from Canada

Amylyx Pharmaceuticals recently announced that Canada has approved ‘Albrioza’, its treatment for neurodegenerative disease amyotrophic lateral sclerosis (ALS). This is considered to be the first certification for oral medicine given by Canada.

The combination of orally active chemicals sodium phenylbutyrate and taurursodiol known as Albrioza has been approved in Canada for the first time, signaling Amylyx's transition from advancement to a commercial-stage business.

The decision was based on the data released during a global late-stage study involving around 600 patients, by 2024, as well as the completion of subsequent investigations. The drug's approval appears to be based on mid-stage research among 137 patients and a long-term follow-up period that demonstrated it reduced the deterioration in physical functioning among the participants.

The cause of ALS is unknown, but studies cite that it causes nerve impulses in the spinal cord and the brain to break down, further impairing physical function and eventually leading to death. According to Amylyx, around 3,000 Canadians are living with ALS, with an average life expectancy of two to five years after the onset of symptoms.

The company declared that Albrioza will be available in Canada within the next six weeks and that it will collaborate on access with the pan-Canadian Pharmaceutical Alliance, which undertakes price negotiations with manufacturers for government drug programs, as well as the federal, provincial, and territorial governments.

According to Tammy Moore, chief executive of the ALS Society of Canada, ALS is a deadly disease that can strike at any time. It's vital that all Canadians, regardless of where they live, benefit from such innovative medicines and other upcoming advances as soon as possible after regulatory approval. As she believes more time wasted will increase its severity and cause a high death rate.

ALS, also known as Lou Gehrig's disease, sprang to prominence in 2014 because of the "Ice Bucket Challenge," in which individuals filmed themselves spilling ice-cold water over their heads to promote awareness.

Source Credits:

https://financialpost.com/pmn/business-pmn/amylyx-gets-first-approval-for-als-drug-from-canada

About Author

Pankaj Singh . .

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Moderna’s new bivalent booster stand strong against Omicron subvariants

Moderna’s new bivalent booster stand strong against Omicron subvariants

Published Date: 2022-06-24         Author: Pankaj Singh

As per reliable sources, Moderna Inc. announced that its modified COVID-19 vaccine induces a potent immune response against the Omicron subvariants BA.4 and BA.5 which have recently spread throughout the United States. Additionally, the biotech major expressed optimism that its bivalent vaccine, ... Read More>>

StashFin secures USD 270 million in fresh funding to expand its reach

StashFin secures USD 270 million in fresh funding to expand its reach

Published Date: 2022-06-23         Author: Pankaj Singh

Neo-banking startup StashFin has reportedly raised USD 200 million in debt by Fasanara Capital and Abstract Ventures, along with a USD 70 million equity capital led by San Francisco-based Uncorrelated Ventures. With the latest funding, the company is now valued at USD 800 million. The fundraising... Read More>>

British airline EasyJet to buy 56 aircraft from Airbus for USD 6.5 Bn

British airline EasyJet to buy 56 aircraft from Airbus for USD 6.5 Bn

Published Date: 2022-06-22         Author: Pankaj Singh

EasyJet plc is reportedly planning to buy about 56 Airbus SE’s A320neo air jets to honor its 2013 agreement with the European aircraft manufacturer, as well as upgrade its previous order to 18 new A321neo aircraft. According to the British airline, the proposed order, which is currently awa... Read More>>

© 2022 Fractovia. All Rights Reserved